Healthcare startups on biotech, stem cell research and diagnosis to lead innovation: Ratan Tata

HYDERABAD: Healthcare startups focused on biotechnology, stem cell research and diagnosis will be at the forefront of the next wave of innovation, said Ratan Tata, chairman emeritus of Tata Sons.

"Going ahead, cancer research, medical breakthrough and startups which deal with imaging and analysis will be the next big wave," Tata, now an active investor in startups, said at the inauguration of the Telangana government-run incubator, T Hub, on Thursday.

The incubator, established at Rs. 40 crore, will have a cost of corpus of Rs 10 crore.

It has signed a pact with software industry body Nasscom's 10,000 Startups initiative and Internet and Mobile Association of India's 10X programme to promote the mobile application developer ecosystem.